Heffernan Michael Thomas

Heffernan Michael Thomas is listed in filings as Director at enGene Holdings Inc.. This profile follows SEC Form 4 activity through Jun 17, 2026, including 8 public disclosures. Recent filings connect the profile to enGene Holdings Inc. (ENGN), Trevi Therapeutics, Inc. (TRVI), Collegium Pharmaceutical, Inc. (COLL), and Avalo Therapeutics, Inc. (AVTX). The current snapshot covers public activity from Jun 14, 2024 to Jun 17, 2026. Reported amounts are shown as $54.3K to $281.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.